GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹1,195 Cr | ₹1,635 Cr | ₹2,320 Cr | ₹2,084 Cr | ₹1,698 Cr |
What is the latest Operating Profit of GLENMARK PHARMACEUTICALS ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹1,195 Cr |
| Mar2024 | ₹1,635 Cr |
| Mar2023 | ₹2,320 Cr |
| Mar2022 | ₹2,084 Cr |
| Mar2021 | ₹1,698 Cr |
How is Operating Profit of GLENMARK PHARMACEUTICALS Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,195 Cr | -26.89 | |
| Mar2024 | ₹1,635 Cr | -29.53 | |
| Mar2023 | ₹2,320 Cr | 11.32 | |
| Mar2022 | ₹2,084 Cr | 22.75 | |
| Mar2021 | ₹1,698 Cr | - | |
Compare Operating Profit of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹61,515.4 Cr | 1.2% | -6.7% | 31.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,803.0 Cr | 2.8% | 1.8% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,219.0 Cr | -0.2% | -0.1% | 3.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,417.0 Cr | 1.4% | -1.5% | 39.9% | Stock Analytics | |
| CIPLA | ₹116,116.0 Cr | 6% | 1.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,874.0 Cr | 4.8% | -0.3% | -0.9% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 1.2% |
-6.7% |
31.4% |
| SENSEX | -0.2% |
2.1% |
-5.6% |
You may also like the below Video Courses